MindWalk Holdings HYFT
NASDAQ HYFT
$1.33 +0.00 (+0.00%)
As of: Sep 4, 2026 · 2:23 PM EDT

MindWalk Holdings (HYFT) Other Operating Expenses (2020 - 2026)

MindWalk Holdings (HYFT) posted quarterly Other Operating Expenses of $70762.1 for Q2 2026, up 125.82% year-over-year from $31335.7 in Q2 2025, and up 135.84% quarter-over-quarter from -$197436.1 in Q1 2026.

Analysis

MindWalk Holdings (HYFT) Other Operating Expenses (2020 - 2026) Analysis & Trends

MindWalk Holdings (HYFT) has reported Other Operating Expenses for 7 consecutive years, with $70762.1 the latest figure, recorded in Q2 2026.

  • In Q2 2026, Other Operating Expenses rose 125.82% year-over-year to $70762.1; the TTM figure through Apr 2026 stood at -$443278.0 (up 14.04% YoY), while the FY2026 annual figure was -$448646.2, up 13.56% from the prior year.
  • Other Operating Expenses advanced to $70762.1 in Q2 2026 per HYFT's latest filing, from -$197436.1 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $9.8 million in Q3 2022 and bottomed at -$12.3 million in Q2 2022.
  • Historically, Other Operating Expenses has averaged $137513.8 across 5 years, with a median of -$7021.1 in 2023.
  • Annual changes were most pronounced in 2022 — Other Operating Expenses jumped 7858.36% — and 2025, when it tumbled 907.83%.
  • MindWalk Holdings' Other Operating Expenses stood at $261254.7 in 2022, then tumbled by 35.07% to $169623.6 in 2023, then sank by 196.7% to -$164032.7 in 2024, then sank by 84.14% to -$302048.3 in 2025, then soared by 123.43% to $70762.1 in 2026.
  • Business Quant data shows HYFT's Other Operating Expenses at $70762.1 in Q2 2026, -$197436.1 in Q1 2026, and -$302048.3 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.40 Bn 27.56 Bn -
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn
10 MindWalk Holdings 61.69 Mn 53.41 Mn 1.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 70,762.08
Jan 31, 2026 -197,436.10
Oct 31, 2025 -302,048.30
Jul 31, 2025 -14,555.71
Apr 30, 2025 -274,064.19
Jan 31, 2025 -74,669.25
Oct 31, 2024 -164,032.67
Jul 31, 2024 -2,921.25
Apr 30, 2024 33,925.93
Jan 31, 2024 -86,547.41
Oct 31, 2023 169,623.59
Jul 31, 2023 163,326.43
Apr 30, 2023 22,910.52
Jan 31, 2023 -11,120.92
Oct 31, 2022 261,254.71
Jul 31, 2022 4.92 Mn
Apr 30, 2022 -6.86 Mn
Jan 31, 2022 3.47 Mn
Oct 31, 2021 3.28 Mn
Jul 31, 2021 3.65 Mn